Pharma Guide to U.S. Proclamation 11020

🔒What pharmaceutical companies importing into the U.S. need to know about Section 232, the tariff rules, CBP guidance and the four Annexes.

About This Guide

This guide, aimed at customs professionals working in the Pharma Sector, offers a comprehensive, entry-by-entry compliance blueprint based on the new U.S. Pharma Tariffs.

This guide breaks down the full HTSUS Chapter 99 architecture , explains how to legally navigate tariff tiers ranging from 0% to 100%, and details how to leverage specific exemptions for generic drugs, specialty pharmaceuticals, and clinical trial/R&D imports.

Readers get actionable, step-by-step decision workflows for product-level mapping, clear guidelines for aligning corporate onshoring or MFN pricing agreements with broker filing instructions, auditable evidence checklists, strategies for Foreign Trade Zones and duty drawback, and an expert analysis of the latest CBP directives and all four Proclamation Annexes.

Want to read more?

Subscribe to customsmanager.info to keep reading this exclusive post.

Subscribe Now